TY - JOUR
T1 - Succoring the challenging acute mesenteric ischemia: Feasibility of lactate dehydrogenase for evaluation of intestinal necrosis extension and mortality
T2 - Viabilidad de la lactato deshidrogenasa para evaluar la extensión de la necrosis intestinal y la mortalidad
AU - Conde Monroy, Danny Michell
AU - Girón Arango, Felipe
AU - Rodríguez Moreno, Lina
AU - Rey Chaves, Carlos Eduardo
AU - Donoso-Samper, Andrea
AU - Nassar, Ricardo
AU - Isaza-Restrepo, Andrés
N1 - Publisher Copyright:
© 2022 The Authors
PY - 2022/12
Y1 - 2022/12
N2 - Background: Acute mesenteric ischemia is a challenging and lethal pathology for surgeons in the emergency department due to its ambiguous clinical presentation and lack of early diagnostic markers. Serum lactate is considered a relevant biomarker in terms of duration of intestinal necrosis and prediction of mortality. However, its association has been little studied. Therefore, we evaluated the relationship between serum lactate levels on admission, the degree of intestinal necrosis and mortality in patients with acute mesenteric ischemia. Methods: We conducted a retrospective cross-sectional study with prospective database, including patients older than 18 years with mesenteric ischemia who required surgical management between January 2012 and December 2018. We describe the association between serum lactate levels on admission with duration of intestinal necrosis and mortality . . in patients with acute mesenteric ischemia. Results: 74 patients presented with acute mesenteric ischemia, 44 men and 30 women. Mean age was 73.5 ± 10.7 years. A significant association was found between serum lactate levels on admission and mortality (ROC cut-off value of 3.8 mmol/l, sensitivity 81.0% and specificity 76%, LR+3.41 (95% CI: 1.57, 7.40), LR-0.25 ( 95% CI.) -0.45)(P.001). However, no statistically significant association was found between serum lactate levels on admission and duration of intestinal necrosis (ρ = 0.195, 95% CI -0.046, -0.436, P > 0.99). A mortality classification and regression tree were fitted as post hoc analysis. Conclusions: Early diagnosis, prognosis and management of mesenteric ischemia is vital given its high morbidity and mortality. Serum lactate levels on admission can be considered a useful prognostic tool in terms of mortality in patients with acute mesenteric ischemia.
AB - Background: Acute mesenteric ischemia is a challenging and lethal pathology for surgeons in the emergency department due to its ambiguous clinical presentation and lack of early diagnostic markers. Serum lactate is considered a relevant biomarker in terms of duration of intestinal necrosis and prediction of mortality. However, its association has been little studied. Therefore, we evaluated the relationship between serum lactate levels on admission, the degree of intestinal necrosis and mortality in patients with acute mesenteric ischemia. Methods: We conducted a retrospective cross-sectional study with prospective database, including patients older than 18 years with mesenteric ischemia who required surgical management between January 2012 and December 2018. We describe the association between serum lactate levels on admission with duration of intestinal necrosis and mortality . . in patients with acute mesenteric ischemia. Results: 74 patients presented with acute mesenteric ischemia, 44 men and 30 women. Mean age was 73.5 ± 10.7 years. A significant association was found between serum lactate levels on admission and mortality (ROC cut-off value of 3.8 mmol/l, sensitivity 81.0% and specificity 76%, LR+3.41 (95% CI: 1.57, 7.40), LR-0.25 ( 95% CI.) -0.45)(P.001). However, no statistically significant association was found between serum lactate levels on admission and duration of intestinal necrosis (ρ = 0.195, 95% CI -0.046, -0.436, P > 0.99). A mortality classification and regression tree were fitted as post hoc analysis. Conclusions: Early diagnosis, prognosis and management of mesenteric ischemia is vital given its high morbidity and mortality. Serum lactate levels on admission can be considered a useful prognostic tool in terms of mortality in patients with acute mesenteric ischemia.
UR - http://www.scopus.com/inward/record.url?scp=85142426386&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85142426386&partnerID=8YFLogxK
U2 - 10.1016/j.amsu.2022.104922
DO - 10.1016/j.amsu.2022.104922
M3 - Research Article
C2 - 36536700
AN - SCOPUS:85142426386
SN - 2049-0801
VL - 84
JO - Annals of Medicine and Surgery
JF - Annals of Medicine and Surgery
M1 - 104922
ER -